SU-DHL-10细胞、SU-DHL-10人大细胞淋巴瘤细胞
文献支持

SU-DHL-10细胞、SU-DHL-10人大细胞淋巴瘤细胞

收藏
  • ¥1800
  • EK-Bioscience已认证
  • 国内
  • SY4605
  • 2025年08月13日
    avatar
    品牌商
    11钻石会员
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 英文名

      SU-DHL-10

    • 库存

      1x10^6/瓶

    • 供应商

      上海酶研

    • 肿瘤类型

      淋巴瘤

    • 细胞类型

      SU-DHL-10

    • 品系

      SU-DHL-10

    • 组织来源

      人大细胞淋巴瘤

    • 相关疾病

      详询

    • 物种来源

    • 免疫类型

      详询

    • 细胞形态

      贴壁/悬浮

    • 是否是肿瘤细胞

    • 器官来源

      人大细胞淋巴瘤

    • 运输方式

      顺丰快递

    • 年限

      5年

    • 生长状态

      生长良好

    • 规格

    SU-DHL-10细胞系、SU-DHL-10细胞株、SU-DHL-10细胞、SU-DHL-10细胞、SU-DHL-10 大细胞淋巴瘤

    Comments    Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
    Part of: COSMIC cell lines project.
    Part of: MD Anderson Cell Lines Project.
    Population: Caucasian.
    Doubling time: ~15-30 hours (DSMZ=ACC-576).
    Microsatellite instability: Stable (MSS) (Sanger).
    Omics: Array-based CGH.
    Omics: CNV analysis.
    Omics: CRISPR phenotypic screen.
    Omics: Deep exome analysis.
    Omics: Deep quantitative proteome analysis.
    Omics: DNA methylation analysis.
    Omics: miRNA expression profiling.
    Omics: Protein expression by reverse-phase protein arrays.
    Omics: SNP array analysis.
    Omics: Transcriptome analysis by microarray.
    Omics: Transcriptome analysis by RNAseq.
    Omics: Virome analysis using RNAseq.
    Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.

    PubMed=8547074; DOI=10.1111/j.1365-2141.1995.tb05302.x

    Siebert R., Willers C.P., Schramm A., Fossa A., Dresen I.M.G., Uppenkamp M.J., Nowrousian M.R., Seeber S., Opalka B.

    Homozygous loss of the MTS1/p16 and MTS2/p15 genes in lymphoma and lymphoblastic leukaemia cell lines.

    Br. J. Haematol. 91:350-354(1995)

     

    PubMed=9738977; DOI=10.1111/j.1349-7006.1998.tb03275.x; PMCID=PMC5921886

    Takizawa J., Suzuki R., Kuroda H., Utsunomiya A., Kagami Y., Joh T., Aizawa Y., Ueda R., Seto M.

    Expression of the TCL1 gene at 14q32 in B-cell malignancies but not in adult T-cell leukemia.

    Jpn. J. Cancer Res. 89:712-718(1998)

     

    PubMed=9787181; DOI=10.1182/blood.V92.9.3410

    Sakai A., Thieblemont C., Wellmann A., Jaffe E.S., Raffeld M.

    PTEN gene alterations in lymphoid neoplasms.

    Blood 92:3410-3415(1998)

     

    DOI=10.1016/B978-0-12-221970-2.50457-5

    Drexler H.G.

    The leukemia-lymphoma cell line factsbook.

    (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001)

     

    PubMed=19278952; DOI=10.1182/blood-2009-01-202028; PMCID=PMC3401058

    Li C., Kim S.-W., Rai D., Bolla A.R., Adhvaryu S., Kinney M.C., Robetorye R.S., Aguiar R.C.T.

    Copy number abnormalities, MYC activity, and the genetic fingerprint of normal B cells mechanistically define the microRNA profile of diffuse large B-cell lymphoma.

    Blood 113:6681-6690(2009)

     

    PubMed=19358282; DOI=10.1002/ijc.24351

    Inagaki A., Ishida T., Yano H., Ishii T., Kusumoto S., Ito A., Ri M., Mori F., Ding J.-M., Komatsu H., Iida S., Ueda R.

    Expression of the ULBP ligands for NKG2D by B-NHL cells plays an important role in determining their susceptibility to rituximab-induced ADCC.

    Int. J. Cancer 125:212-221(2009)

     

    PubMed=20054396; DOI=10.1038/nature08638; PMCID=PMC2845535

    Davis R.E., Ngo V.N., Lenz G., Tolar P., Young R.M., Romesser P.B., Kohlhammer H., Lamy L., Zhao H., Yang Y.-D., Xu W.-H., Shaffer A.L. 3rd, Wright G., Xiao W.-M., Powell J.I., Jiang J.-K., Thomas C.J., Rosenwald A., Ott G., Muller-Hermelink H.-K., Gascoyne R.D., Connors J.M., Johnson N.A., Rimsza L.M., Campo E., Jaffe E.S., Wilson W.H., Delabie J., Smeland E.B., Fisher R.I., Braziel R.M., Tubbs R.R., Cook J.R., Weisenburger D.D., Chan W.-C., Pierce S.K., Staudt L.M.

    Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma.

    Nature 463:88-92(2010)

     

    PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458; PMCID=PMC2881662

    Rothenberg S.M., Mohapatra G., Rivera M.N., Winokur D., Greninger P., Nitta M., Sadow P.M., Sooriyakumar G., Brannigan B.W., Ulman M.J., Perera R.M., Wang R., Tam A., Ma X.-J., Erlander M., Sgroi D.C., Rocco J.W., Lingen M.W., Cohen E.E.W., Louis D.N., Settleman J., Haber D.A.

    A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.

    Cancer Res. 70:2158-2164(2010)

     

    PubMed=20628145; DOI=10.1182/blood-2010-05-282780; PMCID=PMC2995356

    Green M.R., Monti S., Rodig S.J., Juszczynski P., Currie T., O'Donnell E., Chapuy B., Takeyama K., Neuberg D., Golub T.R., Kutok J.L., Shipp M.A.

    Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.

    Blood 116:3268-3277(2010)

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献

    *发表【中文论文】请标注:由上海酶研生物科技有限公司提供;

    *发表【英文论文】请标注:From Shanghai EK-Bioscience Biotechnology Co., Ltd.

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥1400
    上海匹拓生物科技有限公司
    2025年12月04日询价
    询价
    蒂科(上海)生物科技有限公司
    2025年06月08日询价
    ¥1620
    博辉生物科技(广州)有限公司
    2025年12月04日询价
    ¥1200
    上海继和生物科技有限公司
    2025年08月29日询价
    ¥1800
    上海酶研生物科技有限公司
    2025年07月15日询价
    文献支持
    SU-DHL-10细胞、SU-DHL-10人大细胞淋巴瘤细胞
    ¥1800